The Global Generics & Biosimilars Awards is the one night of the year when the off-patent pharmaceutical industry’s greatest achievements are put in the spotlight.
Taking place November 10, 2021 at the Stella Polare, Fiera Milano, Milan, Italy, the Global Generics & Biosimilars Awards 2021 is free to enter and will reward companies across the off-patent industry – including small-molecule generics, biosimilars and value-added medicines – by recognizing their successes over the past year.
Our awards categories crown the industry’s leading companies, both on a global and regional basis; highlight achievements in biosimilars and value-added medicines; and also recognize the industry’s biggest deals, regulatory milestones and company leaders.
API suppliers and other industry partners also have their own categories in which to compete for recognition, while companies are also presented with awards for their CSR activities, their intellectual property strategies and other business development initiatives.
As the world continues to grapple with the COVID-19 pandemic, there has perhaps never been a more appropriate time to recognize the ongoing efforts made by the worldwide off-patent industry to provide access to quality, effective medicines at affordable prices around the globe.
Entry Deadline is July 30, 2021.
Entry Deadline: July 30, 2021
Awards Ceremony: November 10, 2021